Published in Appl Environ Microbiol on June 01, 1986
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature (2011) 3.37
Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur J Immunol (2012) 1.24
Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut (1989) 1.01
Reductive inactivation of digitoxin by Eubacterium lentum cultures. Appl Environ Microbiol (1987) 0.75
Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med (1981) 2.00
Digoxin-inactivating bacteria: identification in human gut flora. Science (1983) 1.68
Urinary excretion of reduced metabolites of digoxin. Am J Med (1981) 1.08
Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis. Clin Pharmacol Ther (1980) 0.96
Transformation of bile acids by Eubacterium lentum. Appl Environ Microbiol (1981) 0.95
Isolation and characterization of fecal bacteria capable of 16 alpha-dehydroxylating corticoids. Appl Environ Microbiol (1980) 0.91
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
Biotransformation of linoleic acid and bile acids by Eubacterium lentum. Appl Environ Microbiol (1984) 0.90
Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora. Trans Assoc Am Physicians (1982) 0.89
Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites. Clin Pharmacol Ther (1981) 0.89
Biochemical characterization of cholesterol-reducing Eubacterium. Appl Environ Microbiol (1980) 0.88
Dihydrodigoxin: a common metabolite of digoxin in man. Drug Metab Dispos (1974) 0.87
Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate. Clin Pharmacol Ther (1983) 0.83
Selective-differential medium for isolation and differentiation of pectinatus from other brewery microorganisms. Appl Environ Microbiol (1981) 0.83
Formation of [20R]-dihydrodigoxin from digoxin in humans. Drug Metab Dispos (1985) 0.82
Digoxigenin biotransformation. Clin Pharmacol Ther (1982) 0.82
Spectral analysis of the configuration and solution conformation of dihydrodigoxigenin epimers. J Pharm Sci (1983) 0.82
Identification by gas chromatography-mass spectroscopy of dihydrodigoxin--a metabolite of digoxin in man. J Pharmacol Exp Ther (1973) 0.82
Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20. J Chromatogr (1976) 0.79
Digoxin and metabolites in urine: a derivatization--high-performance liquid chromatographic method capable of quantitating individual epimers of dihydrodigoxin. J Chromatogr (1984) 0.79
Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.78
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA (1998) 9.32
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco. J Acquir Immune Defic Syndr (1999) 2.28
Permeability barrier to rifampin in mycobacteria. Antimicrob Agents Chemother (1977) 2.09
Delayed hemorrhage as a manifestation of occult vascular injury. Mil Med (1993) 2.03
Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl-treated rats. A study of structure-activity relationships. J Biol Chem (1983) 1.91
Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit Rev Toxicol (1990) 1.78
Genome-wide association study of body mass index in 23 000 individuals with and without asthma. Clin Exp Allergy (2013) 1.74
Identification of catechol and hydroquinone metabolites of 4-monochlorobiphenyl. Chem Res Toxicol (1996) 1.69
Synthesis of hydroxylated PCB metabolites with the Suzuki-coupling. Chemosphere (2001) 1.69
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1. J Clin Microbiol (1992) 1.62
Metabolic activation of PCBs to quinones: reactivity toward nitrogen and sulfur nucleophiles and influence of superoxide dismutase. Chem Res Toxicol (1996) 1.49
Cardiac failure with tonsil and adenoid hypertrophy. Arch Otolaryngol (1973) 1.46
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet (2000) 1.34
Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34
Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. J Clin Pharmacol New Drugs (1973) 1.34
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs): implications for PCB-induced oxidative stress in breast cancer. Chem Res Toxicol (1996) 1.31
Models of retinoid metabolism: microbial biotransformation of alpha-ionone and beta-ionone. J Nat Prod (1989) 1.28
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Synthesis of polychlorinated biphenyls (PCBs) using the Suzuki-coupling. Chemosphere (2001) 1.16
Production of DNA strand breaks in vitro and reactive oxygen species in vitro and in HL-60 cells by PCB metabolites. Toxicol Sci (2001) 1.16
The pleiotropic effect of spontaneous single-step variant production in Mycobacterium intracellulare. Scand J Respir Dis (1978) 1.16
Analytical characterization of recently excavated megalithic sarcophagi potsherds in Veeranam village, Tiruvannamalai dist., Tamilnadu, India. Spectrochim Acta A Mol Biomol Spectrosc (2013) 1.13
Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat. Biochem Pharmacol (1985) 1.11
The PHF11 gene is not associated with asthma or asthma phenotypes in two independent populations. Thorax (2009) 1.10
Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. J Infect Dis (2001) 1.09
Comparison of theoretical scattering results and ultrasonic data from clinical liver examinations. Ultrasound Med Biol (1988) 1.09
Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J Biochem Toxicol (1995) 1.08
Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin Pharmacol Ther (2008) 1.08
Sulfhydryl binding and topoisomerase inhibition by PCB metabolites. Chem Res Toxicol (2002) 1.06
Biologically relevant phosphoranes: synthesis and structural characterization of glucofuranose-derived phosphoranes with penta- and hexacoordination at phosphorus. Inorg Chem (2006) 1.05
Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharm Bull (1996) 1.04
Physiological studies on ergot: further studies on the induction of alkaloid synthesis by tryptophan and its inhibition by phosphate. J Bacteriol (1972) 1.03
A new strategy for the synthesis of polychlorinated biphenyl metabolites. Chem Res Toxicol (1995) 1.02
Antioxidant protection against PCB-mediated endothelial cell activation. Toxicol Sci (1999) 1.01
Effects of selected polychlorinated biphenyl (PCB) congeners on hepatic glutathione, glutathione-related enzymes, and selenium status: implications for oxidative stress. Biochem Pharmacol (2001) 1.00
Membrane filtration method for the evaluation of quaternary ammonium disinfectants. Lab Pract (1972) 1.00
Redox cycling of 2-(x'-mono, -di, -trichlorophenyl)- 1, 4-benzoquinones, oxidation products of polychlorinated biphenyls. Arch Biochem Biophys (2000) 0.99
Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man. J Pharmacokinet Biopharm (1974) 0.98
Bactericidal action of ascorbic acid on Psuedomonas aeruginosa: alteration of cell surface as a possible mechanism. Chemotherapy (1978) 0.98
Changes in the prevalence of asthma in adults since 1966: the Busselton health study. Eur Respir J (2009) 0.98
Development of a synthetic PCB mixture resembling the average polychlorinated biphenyl profile in Chicago air. Environ Int (2009) 0.98
Polychlorinated biphenyl-induced effects on metabolic enzymes, AP-1 binding, vitamin E, and oxidative stress in the rat liver. Toxicol Appl Pharmacol (2001) 0.97
Differential potency of atropisomers of polychlorinated biphenyls on cytochrome P450 induction and uroporphyrin accumulation in the chick embryo hepatocyte culture. Biochem Pharmacol (1991) 0.97
Polysaccharides in fungi. XXXII. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull (1993) 0.96
Influence of dietary fat on the enantioselective disposition of 2,2',3,3',6,6'-hexachlorobiphenyl (PCB 136) in female mice. Food Chem Toxicol (2007) 0.96
Cellular glutathione status modulates polychlorinated biphenyl-induced stress response and apoptosis in vascular endothelial cells. Toxicol Appl Pharmacol (2000) 0.96
Biologically relevant phosphoranes: structural characterization of glucofuranose- and xylofuranose-based phosphoranes. Inorg Chem (2006) 0.96
PCBs and PBBs: biologic and toxic effects on C57BL/6J and DBA/2J inbred mice. Toxicology (1984) 0.96
Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet (1999) 0.96
The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicol Appl Pharmacol (2001) 0.95
Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord (2012) 0.95
Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther (1985) 0.95
Analysis of polychlorinated biphenyl-DNA adducts by 32P-postlabeling. Carcinogenesis (1996) 0.95
Halogenated biphenyls: molecular toxicology. Can J Physiol Pharmacol (1982) 0.95
Two antimicrobial alkaloids from heartwood of Liriodendron tulipifera L. J Pharm Sci (1975) 0.94
Detection of PCB adducts by the 32P-postlabeling technique. Chem Res Toxicol (1996) 0.94
Influence of fluoro-substitution on the planarity of 4-chlorobiphenyl (PCB 3). Acta Crystallogr B (2007) 0.93
Ocular complications of paediatric patients with nephrotic syndrome. Clin Experiment Ophthalmol (2001) 0.93
Reconstituted human breast milk PCBs as potent inducers of aryl hydrocarbon hydroxylase. Biochem Biophys Res Commun (1980) 0.92
Observations on the natural history of pulmonary artery coarctations. Circulation (1972) 0.91
Linoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells. J Biochem Mol Toxicol (1999) 0.91
Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man. J Pharmacokinet Biopharm (1979) 0.91
Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity. J Med Chem (1991) 0.91
Effects of lipids and antioxidants on PCB-mediated dysfunction of vascular endothelial cells (EC). Cent Eur J Public Health (2000) 0.91
Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11-dUTP. Blood (1993) 0.90
Distribution and macromolecular binding of benzo[a]pyrene and two polychlorinated biphenyl congeners in female mice. Chem Biol Interact (2001) 0.90
Dimerization and activation of porcine pancreatic phospholipase A2 via substrate level acylation of lysine 56. J Biol Chem (1989) 0.90
Infection control for SARS in a tertiary paediatric centre in Hong Kong. J Hosp Infect (2004) 0.90
Synthesis and antimicrobial evaluation of N-D-alanyl-1-aminoethylphosphonic acid. J Med Chem (1975) 0.89
Polychlorinated biphenyls as inducers of hepatic microsomal enzymes: effects of di-ortho substitution. Chem Biol Interact (1981) 0.88
Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol (1995) 0.87
Focal dermal hypoplasia syndrome: (a case report). Indian J Pediatr (1982) 0.87
Antibacterial action of the essential oils of some Australian Myrtaceae with special references to the activity of chromatographic fractions of oil of Eucalyptus citriodora. Planta Med (1974) 0.87
Microbiological oxidation of the pentyl side chain of cannabinoids. Experientia (1978) 0.87
Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique. J Chromatogr (1986) 0.87
Effects of two prototypic polychlorinated biphenyls (PCBs) on lipid composition of rat liver and serum. J Nutr Biochem (1990) 0.87
A comparison of two surgical techniques for preparation of rats with chronic bile duct cannulae for the investigation of enterohepatic circulation. Lab Anim Sci (1994) 0.86
Receptor interactions by polybrominated diphenyl ethers versus polychlorinated biphenyls: a theoretical Structure-activity assessment. Environ Toxicol Pharmacol (2008) 0.86
Recurrent and novel mutations of GCDH gene in Chinese glutaric acidemia type I families. Hum Mutat (2000) 0.86
PCB153 reduces telomerase activity and telomere length in immortalized human skin keratinocytes (HaCaT) but not in human foreskin keratinocytes (NFK). Toxicol Appl Pharmacol (2011) 0.85
Enzymatic halogenation of flavanones and flavones. Phytochemistry (2001) 0.85
Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation. Arch Toxicol (1992) 0.85
A structural model to explain the partial catalytic activity of human prorenin. Am J Hypertens (1989) 0.84
Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry (1998) 0.84
Hepatic microsomal enzyme induction by 2,2', 3,3', 4,4'- and 2,2', 3', 4,4', 5-hexachlorobiphenyl. Life Sci (1980) 0.84
Multimedia manuscript: laparoscopic resection of hepatocellular carcinoma at segment 7: the posterior approach to anatomic resection. Surg Endosc (2011) 0.84
2-(4'-CHLOROPHENYL)-1,4-BENZOQUINONE INCREASES THE FREQUENCY OF MICRONUCLEI AND SHORTENS TELOMERES. Environ Toxicol Pharmacol (2008) 0.84
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Res Commun Chem Pathol Pharmacol (1975) 0.83
Red eyes as the initial presentation of systemic meningococcal infection. J Paediatr Child Health (2003) 0.83
Airborne polychlorinated biphenyls (PCBs) reduce telomerase activity and shorten telomere length in immortal human skin keratinocytes (HaCat). Toxicol Lett (2011) 0.83
Fever, pulmonary haemorrhage, and acute renal failure in a young girl. Hong Kong Med J (2005) 0.83
Polybrominated biphenyls as aryl hydrocarbon hydroxylase inducers: structure-activity correlations. Chem Biol Interact (1982) 0.83
Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies. Med J Aust (1974) 0.83
Estimation of area under the curve for drugs subject to enterohepatic cycling. J Pharmacokinet Biopharm (1985) 0.83